| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,858 |
6,933 |
$610K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,229 |
11,761 |
$601K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,881 |
4,385 |
$566K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,205 |
1,103 |
$286K |
| 87428 |
|
3,683 |
3,449 |
$140K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,040 |
3,576 |
$91K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,268 |
2,162 |
$78K |
| 70450 |
Computed tomography, head or brain; without contrast material |
825 |
754 |
$69K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
976 |
912 |
$59K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,207 |
2,736 |
$55K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
270 |
243 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,916 |
2,308 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,191 |
6,903 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
2,847 |
2,588 |
$27K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,400 |
2,096 |
$24K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
866 |
801 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,185 |
1,078 |
$19K |
| 80053 |
Comprehensive metabolic panel |
3,372 |
2,850 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,211 |
2,816 |
$17K |
| 81025 |
|
4,571 |
4,112 |
$17K |
| 80051 |
|
4,677 |
4,185 |
$16K |
| 82550 |
|
4,758 |
4,226 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,000 |
1,882 |
$14K |
| 84484 |
|
2,742 |
2,237 |
$13K |
| 82977 |
|
3,543 |
3,232 |
$13K |
| 82150 |
|
3,579 |
3,262 |
$12K |
| 82565 |
|
4,677 |
4,185 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,659 |
743 |
$10K |
| 82947 |
|
5,125 |
4,355 |
$10K |
| 84520 |
|
4,678 |
4,186 |
$10K |
| 84460 |
|
3,327 |
3,043 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
746 |
612 |
$9K |
| 84075 |
|
3,326 |
3,042 |
$9K |
| 84450 |
|
3,328 |
3,044 |
$8K |
| 82247 |
|
3,326 |
3,042 |
$8K |
| 82040 |
|
3,326 |
3,042 |
$8K |
| 81003 |
|
6,782 |
6,102 |
$7K |
| 84155 |
|
3,329 |
3,044 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
250 |
234 |
$6K |
| 80305 |
|
977 |
887 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
254 |
240 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
241 |
228 |
$5K |
| 83880 |
|
317 |
290 |
$5K |
| 83605 |
|
690 |
613 |
$4K |
| 85379 |
|
574 |
530 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
633 |
590 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,441 |
1,272 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
83 |
75 |
$2K |
| 87420 |
|
332 |
310 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,477 |
1,281 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
416 |
392 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
381 |
306 |
$1K |
| 73610 |
|
26 |
25 |
$735.23 |
| 96376 |
|
73 |
55 |
$724.08 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
37 |
36 |
$715.21 |
| 73630 |
|
27 |
24 |
$686.64 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
21 |
17 |
$667.17 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,535 |
1,394 |
$584.43 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
717 |
625 |
$451.93 |
| 82805 |
|
31 |
27 |
$310.17 |
| 84702 |
|
39 |
37 |
$296.98 |
| 87400 |
|
44 |
21 |
$294.48 |
| 73030 |
|
14 |
13 |
$225.55 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
46 |
39 |
$187.20 |
| 36415 |
Collection of venous blood by venipuncture |
167 |
154 |
$171.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
146 |
126 |
$108.79 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
44 |
40 |
$40.82 |
| 87210 |
|
12 |
12 |
$23.28 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
100 |
98 |
$6.25 |